Goldman Sachs’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-28,690
| Closed | -$336K | – | 4843 |
|
|
2020
Q3 | $336K | Buy |
+28,690
| New | +$336K | ﹤0.01% | 3843 |
|
|
2020
Q1 | – | Sell |
-10,970
| Closed | -$182K | – | 4612 |
|
|
2019
Q4 | $182K | Sell |
10,970
-2,002
| -15% | -$33.2K | ﹤0.01% | 4009 |
|
|
2019
Q3 | $216K | Sell |
12,972
-141,835
| -92% | -$2.36M | ﹤0.01% | 3894 |
|
|
2019
Q2 | $2.13M | Buy |
154,807
+139,417
| +906% | +$1.92M | ﹤0.01% | 2772 |
|
|
2019
Q1 | $265K | Sell |
15,390
-152
| -1% | -$2.62K | ﹤0.01% | 3785 |
|
|
2018
Q4 | $199K | Sell |
15,542
-14,207
| -48% | -$182K | ﹤0.01% | 3747 |
|
|
2018
Q3 | $483K | Sell |
29,749
-33,431
| -53% | -$543K | ﹤0.01% | 3468 |
|
|
2018
Q2 | $814K | Buy |
63,180
+31,840
| +102% | +$410K | ﹤0.01% | 3304 |
|
|
2018
Q1 | $390K | Buy |
31,340
+20,598
| +192% | +$256K | ﹤0.01% | 3599 |
|
|
2017
Q4 | $150K | Sell |
10,742
-2,854
| -21% | -$39.9K | ﹤0.01% | 3887 |
|
|
2017
Q3 | $228K | Sell |
13,596
-19,627
| -59% | -$329K | ﹤0.01% | 3838 |
|
|
2017
Q2 | $559K | Sell |
33,223
-2,455
| -7% | -$41.3K | ﹤0.01% | 3473 |
|
|
2017
Q1 | $553K | Buy |
35,678
+22,704
| +175% | +$352K | ﹤0.01% | 3455 |
|
|
2016
Q4 | $194K | Sell |
12,974
-4,682
| -27% | -$70K | ﹤0.01% | 3899 |
|
|
2016
Q3 | $222K | Buy |
+17,656
| New | +$222K | ﹤0.01% | 3868 |
|
|
2016
Q2 | – | Sell |
-13,244
| Closed | -$131K | – | 4698 |
|
|
2016
Q1 | $131K | Buy |
+13,244
| New | +$131K | ﹤0.01% | 3943 |
|